'''Cingestol''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) (former tentative brand name '''Lutisan'''),<ref>{{cite book|title=Registry of Toxic Effects of Chemical Substances|url=https://books.google.com/books?id=dRFV2ZV6DT0C|year=1987|publisher=National Institute for Occupational Safety and Health|page=2995}}</ref> also known as '''17α-ethynylestr-5-en-17β-ol''',<ref name="Brotherton1976">{{cite book|author=Janet Brotherton|title=Sex hormone pharmacology|url=https://books.google.com/books?id=zt5sAAAAMAAJ|year=1976|publisher=Academic Press|isbn=978-0-12-137250-7|page=12}}</ref> is a [[steroid]]al [[progestin]] of the [[19-nortestosterone]] group<ref name="Korolkovas1988">{{cite book|author=Andrejus Korolkovas|title=Essentials of Medicinal Chemistry|url=https://books.google.com/books?id=6hxtAAAAMAAJ|date=16 August 1988|publisher=Wiley|isbn=978-0-471-88356-2}}</ref><ref>{{cite book|title=WHO Technical Report Series|url=https://books.google.com/books?id=WlQYAAAAMAAJ|year=1981|publisher=World Health Organization|page=75}}</ref> that was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA279|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=279–}}</ref> It was synthesized in 1969<ref name="Elks2014" /> and was developed in the 1970s by [[Organon International|Organon]] as a low-dose, [[progestogen-only pill|progestogen-only]] [[hormonal contraceptive|contraceptive]],<ref name="Tapingkae1974">{{cite book|author=Amnuay Tapingkae|title=Directory of selected scholars and researchers in Southeast Asia|url=https://books.google.com/books?id=mB4gAQAAMAAJ|year=1974|publisher=Regional Institute of Higher Education and Development|page=687}}</ref><ref name="BriggsBriggs1976">{{cite book|author1=Michael H. Briggs|author2=Maxine Briggs|title=Biochemical contraception: prospects for human development|url=https://books.google.com/books?id=7pRsAAAAMAAJ|year=1976|publisher=Academic Press|isbn=978-0-12-134640-9|page=283}}</ref><ref name="pmid4124151">{{cite journal | vauthors = Aref I, Hefnawi F, Kandil O, Aziz MT | title = Effect of minipills on physiologic responses of human cervical mucus, endometrium, and ovary | journal = Fertil. Steril. | volume = 24 | issue = 8 | pages = 578–83 | year = 1973 | pmid = 4124151 | doi = 10.1016/s0015-0282(16)39850-8| url = http://www.popline.org/node/492373}}</ref><ref name="pmid4375129">{{cite journal | vauthors = Kićović PM, Kovacević S, Djokic LJ, Milojević S, Janoskov J, Behlilović B, Jeremić N | title = Clinical evaluation of a new low dose progestagen-only contraceptive containing cingestol | journal = Int. J. Fertil. | volume = 19 | issue = 3 | pages = 171–5 | year = 1974 | pmid = 4375129 | doi = | url = http://www.popline.org/node/494146}}</ref> but in 1984, was still described as "under investigation".<ref name="CuttingCsáky1984">{{cite book|author1=Windsor Cooper Cutting|author2=T. Z. Csáky|author3=Byron A. Barnes|title=Cutting's Handbook of Pharmacology: The Actions and Uses of Drugs|url=https://books.google.com/books?id=B-1sAAAAMAAJ|year=1984|publisher=Appleton-Century-Crofts|isbn=978-0-8385-1418-4|page=439}}</ref> The drug is an [[isomer]] of [[lynestrenol]] with the double bond between C5 and C6.<ref name="Tausk1975" />
